IF by specialty › Psychiatry
European Neuropsychopharmacology — Impact Factor
The 2025 Impact Factor of European Neuropsychopharmacology is 8.1 (Q1 in Psychiatry; subscription or hybrid).
- Impact Factor
- 8.1 JCR 2025
- JCR category
- Psychiatry
- Quartile
- Q1 in Psychiatry
- Publisher
- Elsevier (ECNP)
- Open access
- subscription or hybrid
- IF source
- sciencedirect.com
Position within the field
Ranked 11 of the 38 journals in Psychiatry on this site (top 50%).
Psychiatry journals with a similar Impact Factor
- Journal of the American Academy of Child & Adolescent Psychiatry IF 9.6
- Psychotherapy and Psychosomatics IF 9.0
- The British Journal of Psychiatry IF 8.5
- European Psychiatry IF 7.9
- Neuropsychopharmacology IF 7.6
- Translational Psychiatry IF 7.5
About this value
The Journal Impact Factor of European Neuropsychopharmacology (JCR 2025, released June 2026) is 8.1. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Psychiatry.